LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
Author: Business Wire
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
Azalea Vision nomina il co-fondatore Andrés Vasquez Quintero a Chief Executive Officer per guidare la prossima fase dello sviluppo clinico
GAND, Belgio–(BUSINESS WIRE)–Azalea Vision, una healthtech belga, oggi ha annunciato che il co-fondatore e CTO Andrés Vasquez Quintero assumerà il ruolo di Chief Executive Officer con effetto immediato, e manterrà anche la carica di CTO. Questa trans…
Azalea Vision nomme son cofondateur, Andrés Vasquez Quintero, au poste de CEO pour mener à bien la nouvelle phase de son développement clinique
GAND, Belgique–(BUSINESS WIRE)–Azalea Vision, une entreprise belge dans le secteur des technologies de la santé, a annoncé aujourd’hui que son cofondateur et CTO Andrés Vasquez Quintero prendra ses nouvelles fonctions de CEO, avec prise d’effet imméd…
Azalea Vision nomme son cofondateur, Andrés Vasquez Quintero, au poste de CEO pour mener à bien la nouvelle phase de son développement clinique
GAND, Belgique–(BUSINESS WIRE)–Azalea Vision, une entreprise belge dans le secteur des technologies de la santé, a annoncé aujourd’hui que son cofondateur et CTO Andrés Vasquez Quintero prendra ses nouvelles fonctions de CEO, avec prise d’effet imméd…
Azalea Vision benoemt medeoprichter Andrés Vasquez Quintero tot CEO om de volgende fase in klinische ontwikkeling te leiden
GENT, België–(BUSINESS WIRE)–Azalea Vision, een Belgisch healthtech-bedrijf, maakte vandaag bekend dat medeoprichter en CTO Andrés Vasquez Quintero met onmiddellijke ingang tot Chief Executive Officer is benoemd, terwijl hij verder als CTO actief bli…
Azalea Vision ernennt Mitbegründer Andrés Vasquez Quintero zum Chief Executive Officer, um die nächste Phase der klinischen Entwicklung voranzutreiben
GENT, Belgien–(BUSINESS WIRE)–Azalea Vision, ein belgisches Healthtech-Unternehmen, gab heute bekannt, dass Mitbegründer und CTO Andrés Vasquez Quintero mit sofortiger Wirkung zum Chief Executive Officer ernannt wird, wobei er weiterhin als CTO tätig…
Azalea Vision nombra como director ejecutivo a su cofundador Andrés Vasquez Quintero para liderar su próxima fase de desarrollo clínico
GANTE, Bélgica–(BUSINESS WIRE)–Azalea Vision, una empresa de tecnología de salud belga, anunció hoy que su cofundador y director de tecnología, Andrés Vasquez Quintero, se convertirá en director ejecutivo, con efecto inmediato, además de continuar co…
Azalea Vision nombra como director ejecutivo a su cofundador Andrés Vasquez Quintero para liderar su próxima fase de desarrollo clínico
GANTE, Bélgica–(BUSINESS WIRE)–Azalea Vision, una empresa de tecnología de salud belga, anunció hoy que su cofundador y director de tecnología, Andrés Vasquez Quintero, se convertirá en director ejecutivo, con efecto inmediato, además de continuar co…
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development
GHENT, Belgium–(BUSINESS WIRE)–Azalea Vision, a Belgian healthtech company, today announced that co-founder and CTO Andrés Vasquez Quintero will become Chief Executive Officer, effective immediately, while continuing as CTO. The transition marks the …
Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sumitomo Pharma America, Inc. (SMPA) today announced that the first patient in its study evaluating DSP-3077 in the treatment of non-syndromic retinitis pigmentosa (RP) has undergone subretinal implantation. DSP-307…
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
Omega Ophthalmics LLC Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule Toward U.S. Approval
LEXINGTON, Ky.–(BUSINESS WIRE)–Omega Ophthalmics Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe
BOLOGNA, Italy & MILAN, Italy–(BUSINESS WIRE)–Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, today announced that it has entered into a share purchase agreement with SEVER Life Sciences B.V. (“SEVER”) for the sale of 100% of the sha…
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Q2 2026 Earnings Release
ForSight Robotics Demonstrates Fully Robotic-Assisted Cataract Surgery Within the Standard Clinical Workflow of the World's Most Commonly Performed Surgical Procedure
CAESAREA, Israel–(BUSINESS WIRE)–ForSight Robotics, a global pioneer in robotic eye surgery, today announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract surgery can be s…